3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
43
Lymphoma, Follicular
23
Lymphoma, Non-Hodgkin
17
Lymphoma, Mantle-Cell
16
Lymphoma, Large B-Cell, Diffuse
15
Lymphoma
14
Lymphoma, B-Cell, Marginal Zone
12
Lymphoma, B-Cell
8
Recurrence
7
Neoplasms
6
Burkitt Lymphoma
5
Neoplasm, Residual
3
Leukemia, B-Cell
3
Leukemia, Hairy Cell
2
Leukemia
2
Dendritic Cell Sarcoma, Interdigitating
2
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Part1: Advanced B-cell Malignancies
1
Ovarian Neoplasms
1
Mesothelioma
1
Melanoma
1
Mature B-cell Malignancies
1
Mature B-Cell Malignancies
1
Lymphoproliferative Disorders
1
Lymphatic Diseases
1
Leukemia, Prolymphocytic
1
Interventions
ibrutinib
5
ruxolitinib
3
Sirolimus
3
Mycophenolic Acid
3
fludarabine
2
asciminib
2
Filgrastim
2
Cyclophosphamide
2
posaconazole
1
pegfilgrastim
1
montelukast
1
axatilimab
1
Whole-Body Irradiation
1
Voriconazole
1
Tomography, X-Ray Computed
1
Specimen Handling
1
Saline Solution
1
Rituximab
1
Respiratory Function Tests
1
Proto-Oncogene Proteins c-raf
1
Prednisone
1
Photopheresis
1
Pentostatin
1
Panobinostat
1
Methotrexate
1
Mesna
1
Infliximab
1
Imatinib Mesylate
1
Everolimus
1
Erythropoietin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bronchiolitis Obliterans Syndrome
×
obinutuzumab
×
1 year
×
Clear all
No trials found.